NCM
GILD icon

Nearwater Capital Markets’s Gilead Sciences GILD Stock Holding History

Nearwater Capital Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9M Sell
200,000
-813,000
-80% -$114M 0.66% 50
2025
Q4 		$124M Buy
1,013,000
+423,000
+72% +$51.4M 2.13% 14
2025
Q3 		$65.5M Buy
590,000
+440,000
+293% +$50M 0.88% 26
2025
Q2 		$16.6M Buy
+150,000
New +$16M 0.27% 62

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nearwater Capital Markets's GILD Position: Q1 2026 in Review

Nearwater Capital Markets reduced its Gilead Sciences (GILD) stake by 80% in Q1 2026, selling an estimated $114M and leaving 200,000 shares worth $27.9M. The position accounts for 0.66% of the portfolio, ranked #50.

Nearwater Capital Markets first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $124M in Q4 2025. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nearwater Capital Markets held 200,000 shares of Gilead Sciences worth $27.9M as of Q1 2026.
  • Nearwater Capital Markets sold 813,000 Gilead Sciences shares in Q1 2026, an estimated $114M.
  • Gilead Sciences made up 0.66% of Nearwater Capital Markets's portfolio in Q1 2026, its #50 holding.
  • Nearwater Capital Markets first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • Nearwater Capital Markets's Gilead Sciences position peaked at $124M in Q4 2025.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nearwater Capital Markets's 13F filing for Q1 2026, filed 15 May 2026.